These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 36768582)

  • 21. PURA syndrome in a child with severe developmental delay: a challenging diagnosis.
    Nogueira M; Melo C; Grangeia A; Magalhães T; Soares C; Dias R; Fonseca J; Sampaio M; Sousa R
    Rev Neurol; 2022 Mar; 74(5):170-173. PubMed ID: 35211951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyrostigmine therapy in a patient with VAMP1-related congenital myasthenic syndrome.
    Al-Muhaizea MA; AlQuait L; AlRasheed A; AlHarbi S; Albader AA; AlMass R; Albakheet A; Alhumaidan A; AlRasheed MM; Colak D; Kaya N
    Neuromuscul Disord; 2020 Jul; 30(7):611-615. PubMed ID: 32616363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PURA Syndrome and Myotonia.
    Trau SP; Pizoli CE
    Pediatr Neurol; 2020 Mar; 104():62-63. PubMed ID: 31911028
    [No Abstract]   [Full Text] [Related]  

  • 24. Congenital Myasthenic Syndromes.
    Iyadurai SJP
    Neurol Clin; 2020 Aug; 38(3):541-552. PubMed ID: 32703467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. β2-Adrenergic receptor agonists ameliorate the adverse effect of long-term pyridostigmine on neuromuscular junction structure.
    Vanhaesebrouck AE; Webster R; Maxwell S; Rodriguez Cruz PM; Cossins J; Wickens J; Liu WW; Cetin H; Cheung J; Ramjattan H; Palace J; Beeson D
    Brain; 2019 Dec; 142(12):3713-3727. PubMed ID: 31633155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biallelic loss of function variants in SYT2 cause a treatable congenital onset presynaptic myasthenic syndrome.
    Donkervoort S; Mohassel P; Laugwitz L; Zaki MS; Kamsteeg EJ; Maroofian R; Chao KR; Verschuuren-Bemelmans CC; Horber V; Fock AJM; McCarty RM; Jain MS; Biancavilla V; McMacken G; Nalls M; Voermans NC; Elbendary HM; Snyder M; Cai C; Lehky TJ; Stanley V; Iannaccone ST; Foley AR; Lochmüller H; Gleeson J; Houlden H; Haack TB; Horvath R; Bönnemann CG
    Am J Med Genet A; 2020 Oct; 182(10):2272-2283. PubMed ID: 32776697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Congenital Myasthenic Syndromes].
    Ohno K
    Brain Nerve; 2024 Jan; 76(1):41-45. PubMed ID: 38191138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expanding the spectrum of LAMB2: Pierson syndrome associated with neuromuscular junction disorder in two patients.
    Paiz F; Alawneh I; Nigro E; Gonorazky HD
    Neuromuscul Disord; 2024 Jun; 39():30-32. PubMed ID: 38723581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective Treatment With Albuterol in DOK7 Congenital Myasthenic Syndrome in Children.
    Tsao CY
    Pediatr Neurol; 2016 Jan; 54():85-7. PubMed ID: 26552645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide epigenetic signatures facilitated the variant classification of the PURA gene and uncovered the pathomechanism of PURA-related neurodevelopmental disorders.
    Xiao B; Dai W; Zhan Y; Qiu W; Zhang H; Liu D; Xu N; Yu Y
    Genet Med; 2024 May; 26(8):101167. PubMed ID: 38770750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy.
    Nicole S; Chaouch A; Torbergsen T; Bauché S; de Bruyckere E; Fontenille MJ; Horn MA; van Ghelue M; Løseth S; Issop Y; Cox D; Müller JS; Evangelista T; Stålberg E; Ioos C; Barois A; Brochier G; Sternberg D; Fournier E; Hantaï D; Abicht A; Dusl M; Laval SH; Griffin H; Eymard B; Lochmüller H
    Brain; 2014 Sep; 137(Pt 9):2429-43. PubMed ID: 24951643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1.
    Finlayson S; Palace J; Belaya K; Walls TJ; Norwood F; Burke G; Holton JL; Pascual-Pascual SI; Cossins J; Beeson D
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1119-25. PubMed ID: 23447650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of mutations in the MYO9A gene in patients with congenital myasthenic syndrome.
    O'Connor E; Töpf A; Müller JS; Cox D; Evangelista T; Colomer J; Abicht A; Senderek J; Hasselmann O; Yaramis A; Laval SH; Lochmüller H
    Brain; 2016 Aug; 139(Pt 8):2143-53. PubMed ID: 27259756
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Johannesen KM; Gardella E; Gjerulfsen CE; Bayat A; Rouhl RPW; Reijnders M; Whalen S; Keren B; Buratti J; Courtin T; Wierenga KJ; Isidor B; Piton A; Faivre L; Garde A; Moutton S; Tran-Mau-Them F; Denommé-Pichon AS; Coubes C; Larson A; Esser MJ; Appendino JP; Al-Hertani W; Gamboni B; Mampel A; Mayorga L; Orsini A; Bonuccelli A; Suppiej A; Van-Gils J; Vogt J; Damioli S; Giordano L; Moortgat S; Wirrell E; Hicks S; Kini U; Noble N; Stewart H; Asakar S; Cohen JS; Naidu SR; Collier A; Brilstra EH; Li MH; Brew C; Bigoni S; Ognibene D; Ballardini E; Ruivenkamp C; Faggioli R; Afenjar A; Rodriguez D; Bick D; Segal D; Coman D; Gunning B; Devinsky O; Demmer LA; Grebe T; Pruna D; Cursio I; Greenhalgh L; Graziano C; Singh RR; Cantalupo G; Willems M; Yoganathan S; Góes F; Leventer RJ; Colavito D; Olivotto S; Scelsa B; Andrade AV; Ratke K; Tokarz F; Khan AS; Ormieres C; Benko W; Keough K; Keros S; Hussain S; Franques A; Varsalone F; Grønborg S; Mignot C; Heron D; Nava C; Isapof A; Borlot F; Whitney R; Ronan A; Foulds N; Somorai M; Brandsema J; Helbig KL; Helbig I; Ortiz-González XR; Dubbs H; Vitobello A; Anderson M; Spadafore D; Hunt D; Møller RS; Rubboli G;
    Neurol Genet; 2021 Dec; 7(6):e613. PubMed ID: 34790866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. De novo mutations in PURA are associated with hypotonia and developmental delay.
    Tanaka AJ; Bai R; Cho MT; Anyane-Yeboa K; Ahimaz P; Wilson AL; Kendall F; Hay B; Moss T; Nardini M; Bauer M; Retterer K; Juusola J; Chung WK
    Cold Spring Harb Mol Case Stud; 2015 Oct; 1(1):a000356. PubMed ID: 27148565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuromuscular junction involvement in inherited motor neuropathies: genetic heterogeneity and effect of oral salbutamol treatment.
    McMacken G; Whittaker RG; Wake R; Lochmuller H; Horvath R
    J Neurol; 2023 Jun; 270(6):3112-3119. PubMed ID: 36869887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies.
    Belaya K; Rodríguez Cruz PM; Liu WW; Maxwell S; McGowan S; Farrugia ME; Petty R; Walls TJ; Sedghi M; Basiri K; Yue WW; Sarkozy A; Bertoli M; Pitt M; Kennett R; Schaefer A; Bushby K; Parton M; Lochmüller H; Palace J; Muntoni F; Beeson D
    Brain; 2015 Sep; 138(Pt 9):2493-504. PubMed ID: 26133662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel
    Rodríguez-García ME; Cotrina-Vinagre FJ; Arranz-Canales E; Aragón AM; Hernández-Sánchez L; Rodríguez-Fornés F; Carnicero-Rodríguez P; Morales-Conejo M; Martín-Hernández E; Martínez-Azorín F
    J Genet; 2020; 99():. PubMed ID: 32089526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VAMP1-Related Congenital Myasthenic Syndrome: A Case Report and Literature Review.
    Yıldırım M; Yarenci GB; Genç MB; Uçar Çİ; Bayav S; Tekin MN; Bektaş Ö; Teber S
    Neuropediatrics; 2024 Jun; 55(3):200-204. PubMed ID: 38531369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variants in GNAI1 cause a syndrome associated with variable features including developmental delay, seizures, and hypotonia.
    Muir AM; Gardner JF; van Jaarsveld RH; de Lange IM; van der Smagt JJ; Wilson GN; Dubbs H; Goldberg EM; Zitano L; Bupp C; Martinez J; Srour M; Accogli A; Alhakeem A; Meltzer M; Gropman A; Brewer C; Caswell RC; Montgomery T; McKenna C; McKee S; Powell C; Vasudevan PC; Brady AF; Joss S; Tysoe C; Noh G; Tarnopolsky M; Brady L; Zafar M; Schrier Vergano SA; Murray B; Sawyer L; Hainline BE; Sapp K; DeMarzo D; Huismann DJ; Wentzensen IM; Schnur RE; Monaghan KG; Juusola J; Rhodes L; Dobyns WB; Lecoquierre F; Goldenberg A; Polster T; Axer-Schaefer S; Platzer K; Klöckner C; Hoffman TL; MacArthur DG; O'Leary MC; VanNoy GE; England E; Varghese VC; Mefford HC
    Genet Med; 2021 May; 23(5):881-887. PubMed ID: 33473207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.